Tenax Therapeutics Shares Outstanding vs. Price To Book
| TENX Stock | USD 5.36 0.03 0.56% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.53 | 0.72 |
|
|
For Tenax Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tenax Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tenax Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tenax Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tenax Therapeutics over time as well as its relative position and ranking within its peers.
Tenax |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenax Therapeutics. If investors know Tenax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenax Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.05) | Return On Assets (0.66) | Return On Equity (1.14) |
The market value of Tenax Therapeutics is measured differently than its book value, which is the value of Tenax that is recorded on the company's balance sheet. Investors also form their own opinion of Tenax Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenax Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenax Therapeutics' market value can be influenced by many factors that don't directly affect Tenax Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenax Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenax Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenax Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tenax Therapeutics Price To Book vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Tenax Therapeutics's current stock value. Our valuation model uses many indicators to compare Tenax Therapeutics value to that of its competitors to determine the firm's financial worth. Tenax Therapeutics is rated below average in shares outstanding category among its peers. It is rated below average in price to book category among its peers . The ratio of Shares Outstanding to Price To Book for Tenax Therapeutics is about 18,142,150 . Price To Book Ratio is likely to rise to 0.71 in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tenax Therapeutics' earnings, one of the primary drivers of an investment's value.Tenax Price To Book vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Tenax Therapeutics |
| = | 3.41 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Tenax Therapeutics |
| = | 0.19 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Tenax Price To Book Comparison
Tenax Therapeutics is currently under evaluation in price to book category among its peers.
Tenax Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Tenax Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tenax Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Tenax Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Tenax Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | (63.00) | (66.15) | |
| Operating Income | -8.2 M | -8.6 M | |
| Income Before Tax | -7.7 M | -8.1 M | |
| Total Other Income Expense Net | 523.3 K | 549.4 K | |
| Net Loss | -7.7 M | -8.1 M | |
| Income Tax Expense | 1.00 | 0.95 | |
| Net Loss | -7 M | -7.4 M | |
| Non Operating Income Net Other | 20.9 K | 19.8 K | |
| Net Loss | -29.2 M | -27.8 M | |
| Interest Income | 1.4 K | 1.2 K | |
| Net Interest Income | 345.1 K | 362.3 K | |
| Change To Netincome | 25.4 M | 26.7 M | |
| Net Loss | (31.09) | (32.65) | |
| Income Quality | 0.77 | 0.53 | |
| Net Income Per E B T | 0.90 | 1.08 |
Tenax Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Tenax Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tenax Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tenax Therapeutics' important profitability drivers and their relationship over time.
Use Tenax Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tenax Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenax Therapeutics will appreciate offsetting losses from the drop in the long position's value.Tenax Therapeutics Pair Trading
Tenax Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Tenax Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tenax Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tenax Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tenax Therapeutics to buy it.
The correlation of Tenax Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tenax Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tenax Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tenax Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Tenax Therapeutics position
In addition to having Tenax Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Convertibles Funds Thematic Idea Now
Convertibles Funds
Funds or Etfs that invest in debt that is expected to be converted into a predetermined amount of the company equity at some future date. The Convertibles Funds theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Convertibles Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.